In-Depth Analysis of the Peripheral Artery Disease Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

What combination of drivers is leading to accelerated growth in the peripheral artery disease market?
The increase in the occurrence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market. This disease involves the restriction or blockage of arteries outside the heart, primarily in the legs, leading to limited blood circulation and potential health issues. Treatments for peripheral artery disease aim to alleviate symptoms, improve mobility, and diminish the likelihood of serious complications, thereby enhancing the quality of life for patients. As indicated by the American Heart Association, a US-based nonprofit organization, it is projected that in June 2023, between 7 to 12 million individuals in the United States, and 200 million people around the world, will be impacted by this condition. Consequently, the growing incidence of peripheral artery diseases is propelling the advancement of the peripheral artery disease market.

Get Your Peripheral Artery Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What is the projected compound annual growth rate (CAGR) of the peripheral artery disease market from 2025 to 2034, and what factors influence it?
The market for peripheral artery disease has seen robust growth in recent years. The market will expand from $4.31 billion in 2024 to $4.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth experienced in the historical period is due to factors such as the rising prevalence of risk factors, the increasing geriatric population, advancements in clinical research and evidence-based medicine, consciousness and screening initiatives, and government healthcare schemes.

Prospects for the peripheral artery disease market are anticipated to undergo significant expansion in the upcoming years, with the market size anticipated to reach $6.23 billion in 2029, boasting a compound annual growth rate (CAGR) of 7.7%. The surge predicted in this timeline can be tied back to a dedication to patient-focused care, breakthroughs in minimally invasive treatments, the rise of digital health and remote patient monitoring, practices in regenerative medicine, and specialized drug treatments. A slew of key trends in forecast period includes initiatives to promote health equality, the incorporation of wearable tech devices, growth of home-centered rehabilitation, patient-reported outcomes (pros), and move towards outpatient care settings.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What trends are poised to drive the future success of the peripheral artery disease market?
The peripheral artery disease market is seeing a rising trend in the form of technological developments. To stay competitive, prominent firms in this market are resorting to advanced surgical procedures. An example of this occurred in November 2022, when Genesis MedTech Group, a medical device firm based in Singapore, launched the Chocolate Touch paclitaxel DCB catheter. This percutaneous transluminal angioplasty (PTA) catheter is designed to treat patients with superficial femoral artery and popliteal artery disease. It is the only balloon catheter in existence that merges a therapeutic agent application with a new-generation angioplasty platform to address peripheral artery disease. The catheter employs cushion-like structures coated with a therapeutic substance, which expands in minute areas, providing an alternative treatment for peripheral artery disease to the usual drug-coated balloon angioplasty. Consequently, the expanded balloon surface enables more effective drug delivery to the blood vessel walls, eliminating the need for any lasting implants.

What are the major segments of the peripheral artery disease market and their role in driving growth?
The peripheral artery disease market covered in this report is segmented -

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons
2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents
3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters
4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters
5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices
6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices
7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

Which regions are key players in the growth of the peripheral artery disease market?
North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the peripheral artery disease market?
Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Is Covered In The Peripheral Artery Disease Global Market Report?

• Market Size Forecast: Examine the peripheral artery disease market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the peripheral artery disease market for a structured understanding.
• Key Players Overview: Analyze major players in the peripheral artery disease market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the peripheral artery disease market.
• Segment Contributions: Evaluate how different segments drive overall growth in the peripheral artery disease market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the peripheral artery disease market.
• Industry Challenges: Identify potential risks and obstacles affecting the peripheral artery disease market.
• Competitive Landscape: Review strategic developments in the peripheral artery disease market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.